Cassava Sciences Inc vs Roundhill Russell 2000 0DTE Covered Call Strat ETF — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $28.85. The key difference: Roundhill Russell 2000 0DTE Covered Call Strat ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | RDTE | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $4.64 | $34.72 |
52-Week Low | $1.09 | $26.40 |
Enterprise Value | -$33.43M | — |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
RDTE trades at $28.90, up 0.63% with a bearish technical signal from moving averages. The stock shows no valuation or profitability metrics available, but has a history of frequent small dividend payments. Recent news highlights structural risks in its covered call strategy, contributing to negative sentiment.
Outlook remains cautious due to capital erosion risks from the ETF's strategy capping upside. Investment opportunity is limited by lack of fundamental data and bearish technicals. Key risks include NAV deterioration and inability to capture market rallies, warranting careful evaluation.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →